| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.0048 | 1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.00085 | 1 |